NASDAQ:SRCL - Stericycle Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $67.80
  • Forecasted Upside: -0.26 %
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$67.98
▲ +1.69 (2.55%)
1 month | 3 months | 12 months
Get New Stericycle Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SRCL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SRCL

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$67.80
▼ -0.26% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Stericycle in the last 3 months. The average price target is $67.80, with a high forecast of $76.00 and a low forecast of $52.00. The average price target represents a -0.26% upside from the last price of $67.98.
Hold
The current consensus among 8 contributing investment analysts is to hold stock in Stericycle. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 1 sell ratings
9/14/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
12/13/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 1 sell ratings
3/12/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 1 sell ratings
6/10/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
9/8/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings
12/7/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings
2/5/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings
3/7/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/6/2020BMO Capital MarketsBoost Price TargetMarket Perform$68.00 ➝ $74.00High
i
10/15/2020Berenberg BankInitiated CoverageBuy$76.00High
i
10/6/2020Raymond JamesReiterated RatingHoldHigh
i
8/17/2020Bank of AmericaBoost Price TargetUnderperform$44.00 ➝ $52.00High
i
Rating by Gary Bisbee at Bank of America Co.
8/7/2020BMO Capital MarketsBoost Price TargetMarket Perform$55.00 ➝ $68.00Medium
i
7/28/2020Barrington ResearchDowngradeHoldLow
i
Rating by K. Steinke at Barrington Research
6/18/2020Royal Bank of CanadaReiterated RatingBuyHigh
i
5/15/2020Barrington ResearchDowngradeOutperform ➝ Market PerformLow
i
Rating by K. Steinke at Barrington Research
5/13/2020Bank of AmericaReiterated RatingUnderperform$52.00 ➝ $44.00High
i
5/8/2020Royal Bank of CanadaLower Price TargetOutperform$75.00 ➝ $67.00Low
i
4/8/2020Stifel NicolausLower Price TargetBuy$73.00 ➝ $70.00High
i
3/30/2020Robert W. BairdUpgradeNeutral ➝ OutperformHigh
i
Rating by David Manthey at Robert W. Baird
3/4/2020Barrington ResearchReiterated RatingBuy$69.00Medium
i
3/2/2020Robert W. BairdReiterated RatingHold$75.00Low
i
Rating by David Manthey at Robert W. Baird
2/20/2020Robert W. BairdBoost Price TargetNeutral$65.00 ➝ $75.00Low
i
11/27/2019Royal Bank of CanadaInitiated CoverageOutperform$75.00N/A
i
11/27/2019Jefferies Financial GroupInitiated CoverageHold$68.00N/A
i
11/21/2019Jefferies Financial GroupInitiated CoverageHold$68.00High
i
11/21/2019Royal Bank of CanadaInitiated CoverageOutperform$75.00High
i
8/2/2019Robert W. BairdUpgradeUnderperform ➝ Neutral$44.00Medium
i
7/17/2019Bank of AmericaReiterated RatingUnderperform ➝ Underperform$46.00 ➝ $44.00Low
i
4/17/2019Robert W. BairdDowngradeNeutral ➝ Underperform$44.00High
i
3/22/2019BMO Capital MarketsBoost Price TargetMarket Perform$50.00Medium
i
3/11/2019Barrington ResearchLower Price TargetOutperform ➝ Outperform$64.00 ➝ $55.00Low
i
Rating by Kevin Steinke at Barrington Research
3/4/2019BMO Capital MarketsBoost Price TargetPositive ➝ Market Perform$41.00 ➝ $45.00Medium
i
3/1/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy$66.00High
i
12/19/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$56.00 ➝ $44.00Medium
i
11/13/2018Barrington ResearchSet Price TargetMarket Perform ➝ Buy$64.00High
i
Rating by Kevin Steinke at Barrington Research
11/6/2018Robert W. BairdReiterated RatingHoldMedium
i
11/6/2018BMO Capital MarketsLower Price TargetMarket Perform ➝ Market Perform$58.00 ➝ $51.00Medium
i
11/2/2018Bank of AmericaLower Price TargetUnderperform ➝ Underperform$53.00 ➝ $50.00Low
i
11/2/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$70.00 ➝ $56.00Low
i
10/22/2018Bank of AmericaInitiated CoverageUnderperform ➝ Underperform$53.00High
i
10/12/2018Northcoast ResearchReiterated RatingNeutralLow
i
Rating by D. Keiser at Northcoast Research
10/5/2018Barrington ResearchSet Price TargetBuy$72.00Low
i
Rating by Kevin Steinke at Barrington Research
8/6/2018BMO Capital MarketsLower Price TargetMarket Perform ➝ Market Perform$71.00 ➝ $63.00Low
i
8/3/2018Robert W. BairdReiterated RatingHold$70.00Low
i
8/2/2018Jefferies Financial GroupSet Price TargetBuy$75.00High
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
7/12/2018BMO Capital MarketsReiterated RatingHold$71.00Medium
i
6/1/2018Barrington ResearchReiterated RatingBuyMedium
i
Rating by Kevin Steinke at Barrington Research
5/14/2018Barrington ResearchSet Price TargetBuy$75.00Low
i
Rating by Kevin Steinke at Barrington Research
5/4/2018BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$64.00 ➝ $67.00Low
i
2/26/2018Barrington ResearchReiterated RatingBuyMedium
i
Rating by K. Steinke at Barrington Research
2/23/2018BMO Capital MarketsReiterated RatingMarket Perform ➝ Market Perform$72.00 ➝ $64.00Medium
i
2/22/2018Royal Bank of CanadaLower Price TargetUnderperform$75.00 ➝ $61.00High
i
2/13/2018Robert W. BairdUpgradeUnderperform ➝ Neutral$73.00Low
i
1/24/2018BMO Capital MarketsReiterated RatingHold$72.00Low
i
1/19/2018Royal Bank of CanadaBoost Price TargetUnderperform$75.00Low
i
12/28/2017Stifel NicolausReiterated RatingBuy ➝ Buy$85.00Low
i
12/13/2017OppenheimerReiterated RatingHoldLow
i
12/13/2017Jefferies Financial GroupSet Price TargetBuy$83.00Medium
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
11/10/2017Barrington ResearchLower Price TargetOutperform ➝ Outperform$87.00 ➝ $75.00N/A
i
11/10/2017BMO Capital MarketsLower Price TargetMarket Perform$74.00 ➝ $62.00N/A
i
11/9/2017Stifel NicolausReiterated RatingBuy ➝ Buy$95.00 ➝ $85.00N/A
i
11/9/2017Royal Bank of CanadaLower Price TargetUnderperform ➝ Underperform$74.00 ➝ $67.00N/A
i
10/17/2017Jefferies Financial GroupSet Price TargetBuy$108.00N/A
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
9/14/2017William BlairReiterated RatingOurperformLow
i
8/11/2017Jefferies Financial GroupSet Price TargetBuy$108.00N/A
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
8/9/2017BarclaysReiterated RatingOverweight$100.00Low
i
Rating by Jon Windham at Barclays PLC
8/3/2017Jefferies Financial GroupSet Price TargetBuy$108.00High
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
7/13/2017Jefferies Financial GroupReiterated RatingBuy$108.00Low
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
6/29/2017BMO Capital MarketsInitiated CoverageMarket Perform$81.00Low
i
5/22/2017Jefferies Financial GroupSet Price TargetBuy$108.00Low
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
5/15/2017Robert W. BairdDowngradeNeutral ➝ Underperform$74.00 ➝ $73.00Low
i
5/15/2017Deutsche Bank AktiengesellschaftLower Price TargetBuy$14.00 ➝ $10.00Low
i
5/6/2017Jefferies Financial GroupSet Price TargetBuy$108.00High
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
5/5/2017Robert W. BairdDowngradeNeutral ➝ Underperform$74.00 ➝ $73.00Low
i
4/13/2017BarclaysInitiated CoverageOverweight$100.00Medium
i
3/30/2017Jefferies Financial GroupReiterated RatingBuy$108.00Medium
i
Rating by Sean Darby at Jefferies Financial Group Inc.
3/16/2017Jefferies Financial GroupSet Price TargetBuy$108.00Medium
i
Rating by Sean Darby at Jefferies Financial Group Inc.
3/7/2017The Goldman Sachs GroupUpgradeSell ➝ Neutral$62.00 ➝ $79.00N/A
i
2/22/2017Barrington ResearchBoost Price TargetOutperform ➝ Outperform$84.00 ➝ $93.00N/A
i
2/20/2017Raymond JamesReiterated RatingMarket PerformN/A
i
2/16/2017Jefferies Financial GroupReiterated RatingBuy$108.00N/A
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
2/10/2017Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
2/6/2017MacquarieSet Price TargetBuy$100.00N/A
i
Rating by Hamzah Mazari at Macquarie
2/6/2017Stifel NicolausSet Price TargetBuy$90.00N/A
i
Rating by Michael Hoffman at Stifel Nicolaus
1/21/2017Royal Bank of CanadaSet Price TargetSell$74.00N/A
i
Rating by Gary Bisbee at Royal Bank of Canada
11/15/2016WedbushReiterated RatingNeutral$85.00 ➝ $82.00N/A
i
11/9/2016WedbushReiterated RatingNeutral$85.00N/A
i
11/3/2016The Goldman Sachs GroupDowngradeNeutral ➝ Sell$60.00N/A
i
10/28/2016Stifel NicolausUpgradeHold ➝ Buy$90.00N/A
i
Rating by Michael Hoffman at Stifel Nicolaus
10/25/2016Jefferies Financial GroupSet Price TargetBuy$112.50 ➝ $108.00N/A
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
10/5/2016Barrington ResearchReiterated RatingOutperform$100.00 ➝ $88.00N/A
i
9/23/2016Robert W. BairdLower Price TargetNeutral$99.00 ➝ $85.00N/A
i
9/22/2016WedbushLower Price TargetNeutral$95.00 ➝ $85.00N/A
i
9/20/2016Northcoast ResearchDowngradeBuy ➝ NeutralN/A
i
Rating by E. Snyder at Northcoast Research
9/19/2016Royal Bank of CanadaReiterated RatingUnderperform$89.00 ➝ $77.00N/A
i
9/19/2016Royal Bank of CanadaLower Price TargetUnderperform$89.00 ➝ $77.00N/A
i
Rating by Gary Bisbee at Royal Bank of Canada
9/9/2016Imperial CapitalLower Price TargetUnderperform$93.50 ➝ $80.00N/A
i
Rating by Scott Levine at Imperial Capital
9/7/2016Jefferies Financial GroupReiterated RatingBuy$125.00 ➝ $112.50N/A
i
Rating by sean dodge at Jefferies Financial Group Inc.
8/25/2016MacquarieInitiated CoverageNeutral$96.00N/A
i
8/23/2016Jefferies Financial GroupReiterated RatingBuy$125.00N/A
i
Rating by sean dodge at Jefferies Financial Group Inc.
7/29/2016Jefferies Financial GroupReiterated RatingBuy$140.00 ➝ $125.00N/A
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
7/29/2016Wellington ShieldsDowngradeAccumulate ➝ HoldN/A
i
7/29/2016Imperial CapitalDowngradeIn-Line ➝ Underperform$100.00 ➝ $93.50N/A
i
Rating by Scott Levine at Imperial Capital
7/18/2016Jefferies Financial GroupReiterated RatingBuy$140.00N/A
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
5/26/2016Royal Bank of CanadaReiterated RatingSellN/A
i
Rating by Gary Bisbee at Royal Bank of Canada
5/26/2016Imperial CapitalLower Price TargetIn ➝ In-Line$100.00 ➝ $95.00N/A
i
Rating by Scott Levine at Imperial Capital
5/17/2016Jefferies Financial GroupReiterated RatingBuy$140.00N/A
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
5/9/2016WedbushLower Price TargetNeutral$112.00 ➝ $100.00N/A
i
5/2/2016WedbushLower Price TargetNeutral$128.00 ➝ $112.00N/A
i
4/30/2016OppenheimerReiterated RatingHoldN/A
i
Rating by Scott Schneeberger at Oppenheimer Holdings Inc.
4/30/2016Imperial CapitalReiterated RatingHoldN/A
i
Rating by Scott Levine at Imperial Capital
4/29/2016Imperial CapitalBoost Price TargetIn ➝ In-Line$95.00 ➝ $115.00N/A
i
4/29/2016Imperial CapitalReiterated RatingIn ➝ In-Line$115.00 ➝ $95.00N/A
i
4/29/2016Wellington ShieldsUpgradeHold ➝ AccumulateN/A
i
4/29/2016Stifel NicolausDowngradeBuy ➝ HoldN/A
i
4/29/2016Raymond JamesDowngradeOutperform ➝ Market PerformN/A
i
4/29/2016Royal Bank of CanadaDowngradeSector Perform ➝ Underperform$119.00 ➝ $96.00N/A
i
Rating by Gary Bisbee at Royal Bank of Canada
4/18/2016Stifel NicolausReiterated RatingBuy$145.00N/A
i
3/23/2016The Goldman Sachs GroupBoost Price Target$127.00N/A
i
3/22/2016Sterne Agee CRTInitiated CoverageBuy$151.00N/A
i
(Data available from 3/7/2016 forward)
Stericycle logo
Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States, Europe, and internationally. It operates through three segments: North America RWCS; International RWCS; and Domestic Communication and Related Services. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, recall/return, and communication services. The company's services also include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, and compliance services; and regulated recall and returns management communication, logistics, and data management services for expired, withdrawn, or recalled products. In addition, it offers compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names. The company serves healthcare businesses, including hospitals, physician and dental practices, outpatient clinics, long-term care facilities, etc.; retailers and manufacturers; financial and professional service providers; governmental entities; and other businesses. Stericycle, Inc. was founded in 1989 and is headquartered in Bannockburn, Illinois.
Read More

Today's Range

Now: $67.98
$66.16
$68.09

50 Day Range

MA: $67.71
$64.87
$69.77

52 Week Range

Now: $67.98
$38.45
$79.50

Volume

258,740 shs

Average Volume

390,659 shs

Market Capitalization

$6.23 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Frequently Asked Questions

What sell-side analysts currently cover shares of Stericycle?

The following Wall Street research analysts have issued research reports on Stericycle in the last year: Bank of America Co., Barrington Research, Berenberg Bank, BMO Capital Markets, Raymond James, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for SRCL.

What is the current price target for Stericycle?

5 Wall Street analysts have set twelve-month price targets for Stericycle in the last year. Their average twelve-month price target is $67.80, suggesting a possible downside of 0.3%. Berenberg Bank has the highest price target set, predicting SRCL will reach $76.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $52.00 for Stericycle in the next year.
View the latest price targets for SRCL.

What is the current consensus analyst rating for Stericycle?

Stericycle currently has 1 sell rating, 3 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SRCL, but not buy more shares or sell existing shares.
View the latest ratings for SRCL.

What other companies compete with Stericycle?

How do I contact Stericycle's investor relations team?

Stericycle's physical mailing address is 2355 WAUKEGAN ROAD, BANNOCKBURN IL, 60015. The business services provider's listed phone number is 847-367-5910 and its investor relations email address is [email protected] The official website for Stericycle is www.stericycle.com.